Literature DB >> 17590012

Monoclonal antibody production using a new supermacroporous cryogel bioreactor.

Suthasinee Nilsang1, Kutty Selva Nandakumar, Igor Yu Galaev, Sudip Kumar Rakshit, Rikard Holmdahl, Bo Mattiasson, Ashok Kumar.   

Abstract

A supermacroporous cryogel bioreactor has been developed to culture hybridoma cells for long-term continuous production of monoclonal antibodies (mAb). Hybridoma clone M2139, secreting antibodies against J1 epitope (GERGAAGIAGPK; amino acids, 551-564) of collagen type II, are immobilized in the porous bed matrix of a cryogel column (10 mL bed volume). The cells got attached to the matrix within 48 h after inoculation and grew as a confluent sheet inside the cryogel matrix. Cells were in the lag phase for 15 days and secreted mAb into the circulation medium. Glucose consumption and lactic acid production were also monitored, and during the exponential phase (approximately 20 days), the hybridoma cell line consumed 0.75 mM day-1 glucose, produced 2.48 mM day-1 lactic acid, and produced 6.5 microg mL-1 day-1 mAb during the exponential phase. The mAb concentration reached 130 microg mL-1 after continuous run of the cryogel column for 36 days. The yield of the mAb after purification was 67.5 mg L-1, which was three times greater than the mAb yield obtained from T-flask batch cultivation. Even after the exchange of medium reservoir, cells in the cryogel column were still active and had relatively stable mAb production for an extended period of time. The bioreactor was operated continuously for 55 days without any contamination. The results from ELISA as well as arthritis experiments demonstrate that the antibodies secreted by cells grown on the cryogel column did not differ from antibodies purified from the cells grown in commercial CL-1000 culture flasks. Thus, supermacroporous cryogels can be useful as a supporting material for productive hybridoma cell culture. Cells were found to be viable inside the porous matrix of the cryogel during the study period and secreted antibodies continuously. The antibodies thus obtained from the cryogel reactor were found to be functionally active in vivo, as demonstrated by their capacity to induce arthritis in mice.

Entities:  

Mesh:

Substances:

Year:  2007        PMID: 17590012     DOI: 10.1021/bp0700399

Source DB:  PubMed          Journal:  Biotechnol Prog        ISSN: 1520-6033


  8 in total

1.  Thermoresponsive poly(N-vinylcaprolactam) cryogels: synthesis and its biophysical evaluation for tissue engineering applications.

Authors:  Akshay Srivastava; Ashok Kumar
Journal:  J Mater Sci Mater Med       Date:  2010-07-13       Impact factor: 3.896

2.  Disposable polymeric cryogel bioreactor matrix for therapeutic protein production.

Authors:  Era Jain; Ashok Kumar
Journal:  Nat Protoc       Date:  2013-04-04       Impact factor: 13.491

Review 3.  Extracorporeal bioartificial liver for treating acute liver diseases.

Authors:  Ashok Kumar; Anuj Tripathi; Shivali Jain
Journal:  J Extra Corpor Technol       Date:  2011-12

4.  Proliferation of myoblast skeletal cells on three-dimensional supermacroporous cryogels.

Authors:  Deepti Singh; Vijayashree Nayak; Ashok Kumar
Journal:  Int J Biol Sci       Date:  2010-07-03       Impact factor: 6.580

Review 5.  Small-diameter vascular tissue engineering.

Authors:  Dawit G Seifu; Agung Purnama; Kibret Mequanint; Diego Mantovani
Journal:  Nat Rev Cardiol       Date:  2013-05-21       Impact factor: 32.419

6.  Macroporous interpenetrating cryogel network of poly(acrylonitrile) and gelatin for biomedical applications.

Authors:  Era Jain; Akshay Srivastava; Ashok Kumar
Journal:  J Mater Sci Mater Med       Date:  2008-07-03       Impact factor: 3.896

7.  Effect of alpha-ketoglutarate on growth and metabolism of cells cultured on three-dimensional cryogel matrix.

Authors:  Deepti Singh; Tanushree Vishnoi; Ashok Kumar
Journal:  Int J Biol Sci       Date:  2013-05-25       Impact factor: 6.580

8.  Three-dimensional supermacroporous carrageenan-gelatin cryogel matrix for tissue engineering applications.

Authors:  Archana Sharma; Sumrita Bhat; Tanushree Vishnoi; Vijayashree Nayak; Ashok Kumar
Journal:  Biomed Res Int       Date:  2013-07-07       Impact factor: 3.411

  8 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.